Khosla Ventures

Activity from announced rounds

Activity in this selectionSeries B

Khosla Ventures funds technology companies at seed, early and growth stages, including businesses tackling difficult scientific and engineering problems in energy, industry, healthcare and software.

Its investments in fusion and lower-emission cement illustrate an appetite for technical risk in markets where commercialisation requires more than a software launch. The firm also invests in AI and developer businesses, applying the same interest in technology that can change how an industry works.

Its Venture Assistance programme includes candidate shortlists, compensation and hiring-close materials, recruiting events and operator office hours in growth, product marketing, data and sales. Those are practical resources for founders assembling the team and commercial capability around a technical product.

Sources
Rounds participated in
18
Confirmed lead rounds
3
12 roles undisclosed
New companies
18
First participation on record · 0 follow-on
Funding in participating rounds
$1.8B
17 disclosed · full round size, not this investor’s share

By stage

Series B18

By primary sector

Healthtech4
AI3
Climate tech2
Cybersecurity2
Fintech2
5 more
Biotech1
Developer tools1
Industrial tech1
Proptech1
Robotics1

By country

United States14
India2
1
Netherlands1

Rounds

18 in this selection
Even Healthcare

Even Healthcare combines hospital care, care coordination and digital follow-up for patients in India.

$50MSeries B
Lead
Arena

Arena evaluates AI models through comparisons and observations of how people use them in real tasks.

$200MSeries B
Lead
Vinci

Vinci develops AI systems designed to model physical behavior and help robots and other machines operate in real-world environments.

$250MSeries B
Participant
Mazama Energy

A geothermal developer building enhanced geothermal systems that create engineered reservoirs in very hot rock to deliver round-the-clock electricity.

$135MSeries B
Participant
Moonwalk Biosciences

Moonwalk Biosciences is developing adipose-targeted siRNA medicines for obesity and cardiometabolic disease. Its lead programs are designed to alter fat-tissue pathways while limiting effects on other tissues, with the lead obesity candidate in IND-enabling development ahead of planned human testing in 2027.

$70MSeries B
Participant
Split Pay

Split Pay lets consumers divide large monthly bills into two smaller payments on a staggered schedule.

~$100MSeries B
Lead
WindBorne Systems

Operates autonomous sensing balloons and AI models for weather forecasting infrastructure

$37MSeries B
Role not disclosed
Mariana Minerals

Builds and operates AI-driven mines and refineries for critical minerals

$310MSeries B
Role not disclosed
Twenty

Twenty builds AI-enabled cyber warfare systems for the U.S. military and intelligence community

$30MSeries B+
Role not disclosed
Bunkerhill Health

Bunkerhill Health builds an agentic AI platform for health systems to turn their ideas into reality

$25MSeries B
Role not disclosed
Monumental

Developing autonomous robotics and software for the building industry to address labour shortages

$32MSeries B
Role not disclosed
Connie Health

AI-enabled Medicare platform helping seniors navigate healthcare coverage

$40MSeries B
Role not disclosed
Sarvam

Builds AI foundation models and enterprise applications for Indian businesses and governments

$234MSeries B
Role not disclosed
Exaforce

AI-native SOC platform using a real-time knowledge graph and Exabots to detect and respond to threats

$125MSeries B
Role not disclosed
Basis

Provides AI agents for accountants to complete complex accounting workflows end-to-end

$100MSeries B
Role not disclosed
Emergent

Provides AI software creation platform for building full-stack web and mobile applications

$70MSeries B
Role not disclosed
Vista AI

Develops AI-powered MRI automation software for hospitals and imaging centers

$29.5MSeries B
Role not disclosed